Clinical Trials Directory

Trials / Sponsors / Nanobiotix

Nanobiotix

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
Radiotherapy, Immunotherapy, Microsatellite Instability-High Solid Malignant Tumour
Phase 12019-01-16
TerminatedNBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
Prostate Cancer
Phase 1 / Phase 22017-11-15
TerminatedNBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
Liver Cancer
Phase 1 / Phase 22016-01-28
CompletedNBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft T
Adult Soft Tissue Sarcoma
Phase 2 / Phase 32015-03-03
UnknownNBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
Head and Neck Cancer
N/A2014-01-03
CompletedNBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Ex
Adult Soft Tissue Sarcoma
Phase 12011-10-01